Zoetis Inc. $ZTS Shares Sold by King Luther Capital Management Corp

King Luther Capital Management Corp trimmed its stake in Zoetis Inc. (NYSE:ZTS) by 16.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 379,539 shares of the company’s stock after selling 73,626 shares during the period. King Luther Capital Management Corp owned approximately 0.09% of Zoetis worth $26,503,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. BlackRock Inc. grew its stake in Zoetis by 10.8% in the 2nd quarter. BlackRock Inc. now owns 39,430,181 shares of the company’s stock worth $2,833,453,000 after buying an additional 3,845,869 shares in the last quarter. State Street Corp raised its position in shares of Zoetis by 1.8% during the 2nd quarter. State Street Corp now owns 19,667,723 shares of the company’s stock valued at $1,413,323,000 after buying an additional 343,322 shares in the last quarter. Bank of America Corp DE raised its position in shares of Zoetis by 7.3% during the 1st quarter. Bank of America Corp DE now owns 4,831,652 shares of the company’s stock valued at $571,150,000 after buying an additional 327,313 shares in the last quarter. Deutsche Bank AG lifted its holdings in shares of Zoetis by 5.8% during the 2nd quarter. Deutsche Bank AG now owns 5,851,737 shares of the company’s stock worth $420,506,000 after acquiring an additional 319,709 shares during the last quarter. Finally, Van ECK Associates Corp lifted its holdings in shares of Zoetis by 7.7% during the 2nd quarter. Van ECK Associates Corp now owns 4,252,140 shares of the company’s stock worth $305,559,000 after acquiring an additional 303,395 shares during the last quarter. 92.80% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on ZTS. TD Cowen cut their target price on shares of Zoetis from $104.00 to $94.00 and set a “buy” rating for the company in a research report on Tuesday, August 25th. Zacks Research raised Zoetis from a “strong sell” rating to a “hold” rating in a research note on Monday, October 26th. Weiss Ratings upgraded Zoetis from a “sell (d)” rating to a “sell (d+)” rating in a research report on Thursday, October 29th. William Blair downgraded Zoetis from an “outperform” rating to a “market perform” rating in a research report on Thursday, August 6th. Finally, UBS Group lifted their price target on Zoetis from $80.00 to $85.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 27th. Eight research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $101.25.

Zoetis Stock Up 0.2%

Shares of NYSE ZTS opened at $82.59 on Thursday. Zoetis Inc. has a one year low of $68.77 and a one year high of $132.49. The company has a debt-to-equity ratio of 2.51, a current ratio of 2.35 and a quick ratio of 1.40. The firm’s 50 day simple moving average is $75.99 and its two-hundred day simple moving average is $91.97. The stock has a market capitalization of $33.56 billion, a P/E ratio of 12.44, a PEG ratio of 1.19 and a beta of 0.67.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Thursday, November 5th. The company reported $1.75 EPS for the quarter, topping the consensus estimate of $1.51 by $0.24. The firm had revenue of $2.39 billion for the quarter, compared to the consensus estimate of $2.30 billion. Zoetis had a net margin of 26.15% and a return on equity of 85.90%. The business’s revenue was down 1.3% compared to the same quarter last year. During the same period last year, the firm posted $1.70 earnings per share. As a group, analysts expect that Zoetis Inc. will post 6.29 EPS for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 1st. Investors of record on Friday, October 30th will be paid a $0.53 dividend. The ex-dividend date of this dividend is Friday, October 30th. This represents a $2.12 dividend on an annualized basis and a yield of 2.6%. Zoetis’s dividend payout ratio (DPR) is presently 36.05%.

Zoetis Company Profile

Zoetis is an animal health company that discovers, develops, manufactures and markets medicines, vaccines, diagnostic products and other services for animals. Its products support both companion animals, such as dogs and cats, and livestock, including cattle, pigs, poultry, sheep and fish. The company’s offerings include treatments for pain, infections and skin conditions, as well as vaccines, parasiticides, diagnostic tools and genetic testing services. Zoetis serves veterinarians, livestock producers and other animal health professionals around the world.